Patients undergoing evaluation for solid organ transplantation (SOT) often have a history of
malignancy. Although the cancer has been treated in these patients, the benefits of …

Lung transplantation for primary bronchogenic cancer could lead to increased survival and
improved quality of life for patients who have malignant disease, for which other therapies …

Introduction: Chronic obstructive pulmonary disease (COPD) affects more than 380 million
people, causing more than 3 million deaths annually worldwide. Despite this enormous …

The diagnosis, prognostication, and differentiation of phenotypes of COPD can be facilitated
by CT scan imaging of the chest. CT scan imaging of the chest is a prerequisite for lung …

Background Active primary lung malignancy remains a strong contraindication to lung
transplantation (LTx). However, outcomes are unclear for patients with early-stage non-small …

Background Lung transplant (LTx) is an accepted treatment for end-stage pulmonary failure.
A small proportion of explanted lungs harbor incidentally identified nonsmall cell lung …

LTx is the only treatment option with curative intent for ILDs and is increasingly used for this
indication. Several studies have now reported adequate outcomes in different ILD entities …

Purpose Recent history of malignancy without 5-year disease-free interval is an absolute
contraindication for lung transplantation (LTx). However, in rare cases, lung cancer may be …

Background Some studies have reviewed lung explants histology to determine the
frequency of pretransplant non-identified neoplasms or explore its diagnostic correlation …

This case describes a woman in her 20s with a 6-month history of progressive exertional
dyspnoea and cough. Examination revealed hypoxia on room air, sinus tachycardia, finger …